Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorGARCEZ, Flavia B.
dc.contributor.authorALIBERTI, Marlon J. R.
dc.contributor.authorPOCO, Paula C. E.
dc.contributor.authorHIRATSUKA, Marcel
dc.contributor.authorTAKAHASHI, Silvia de F.
dc.contributor.authorCOELHO, Venceslau A.
dc.contributor.authorSALOTTO, Danute B.
dc.contributor.authorV, Marlos L. Moreira
dc.contributor.authorJACOB-FILHO, Wilson
dc.contributor.authorAVELINO-SILVA, Thiago J.
dc.identifier.citationJOURNAL OF THE AMERICAN GERIATRICS SOCIETY, v.68, n.11, p.2440-2446, 2020
dc.description.abstractBACKGROUND Little is known about the association between acute mental changes and adverse outcomes in hospitalized adults with COVID-19. OBJECTIVES To investigate the occurrence of delirium in hospitalized patients with COVID-19 and explore its association with adverse outcomes. DESIGN Longitudinal observational study. SETTING Tertiary university hospital dedicated to the care of severe cases of COVID-19 in Sao Paulo, Brazil. PARTICIPANTS A total of 707 patients, aged 50 years or older, consecutively admitted to the hospital between March and May 2020. MEASUREMENTS We completed detailed reviews of electronic medical records to collect our data. We identified delirium occurrence using the Chart-Based Delirium Identification Instrument (CHART-DEL). Trained physicians with a background in geriatric medicine completed all CHART-DEL assessments. We complemented our baseline clinical information using telephone interviews with participants or their proxy. Our outcomes of interest were in-hospital death, length of stay, admission to intensive care, and ventilator utilization. We adjusted all multivariable analyses for age, sex, clinical history, vital signs, and relevant laboratory biomarkers (lymphocyte count, C-reactive protein, glomerular filtration rate, D-dimer, and albumin). RESULTS Overall, we identified delirium in 234 participants (33%). On admission, 86 (12%) were delirious. We observed 273 deaths (39%) in our sample, and in-hospital mortality reached 55% in patients who experienced delirium. Delirium was associated with in-hospital death, with an adjusted odds ratio of 1.75 (95% confidence interval = 1.15-2.66); the association held both in middle-aged and older adults. Delirium was also associated with increased length of stay, admission to intensive care, and ventilator utilization. CONCLUSION Delirium was independently associated with in-hospital death in adults aged 50 years and older with COVID-19. Despite the difficulties for patient care during the pandemic, clinicians should routinely monitor delirium when assessing severity and prognosis of COVID-19 patients.eng
dc.description.sponsorshipNetwork for Investigation of Delirium: Unifying Scientists [R24AG054259]
dc.relation.ispartofJournal of the American Geriatrics Society
dc.titleDelirium and Adverse Outcomes in Hospitalized Patients withCOVID-19eng
dc.rights.holderCopyright WILEYeng
dc.subject.wosGeriatrics & Gerontologyeng
dc.type.categoryoriginal articleeng
hcfmusp.relation.referenceAlkeridy WA, 2020, J AM GERIATR SOC, V68, P1382, DOI 10.1111/jgs.16536eng
hcfmusp.relation.referenceCastro Roberta E Vieira de, 2020, Braz J Psychiatry, DOI 10.1590/1516-4446-2020-1048eng
hcfmusp.relation.referenceCenters for Disease Control and Prevention, 2020, SEV OUTC PAT COR DISeng
hcfmusp.relation.referenceDesforges M, 2014, ADV EXP MED BIOL, V807, P75, DOI 10.1007/978-81-322-1777-0_6eng
hcfmusp.relation.referenceDiSilvio B, 2019, CRIT CARE NURS Q, V42, P349, DOI 10.1097/CNQ.0000000000000275eng
hcfmusp.relation.referenceFong TG, 2015, LANCET NEUROL, V14, P823, DOI 10.1016/S1474-4422(15)00101-5eng
hcfmusp.relation.referenceFu LW, 2020, J INFECTION, V80, P656, DOI 10.1016/j.jinf.2020.03.041eng
hcfmusp.relation.referenceGuan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032eng
hcfmusp.relation.referenceHarris PA, 2019, J BIOMED INFORM, V95, DOI 10.1016/j.jbi.2019.103208eng
hcfmusp.relation.referenceHelms J, 2020, NEW ENGL J MED, V382, P2268, DOI 10.1056/NEJMc2008597eng
hcfmusp.relation.referenceInouye SK, 2005, J AM GERIATR SOC, V53, P312, DOI 10.1111/j.1532-5415.2005.53120.xeng
hcfmusp.relation.referenceLaHue SC, 2020, J AM GERIATR SOC, V68, P947, DOI 10.1111/jgs.16480eng
hcfmusp.relation.referenceLiang WH, 2020, JAMA INTERN MED, V180, P1081, DOI 10.1001/jamainternmed.2020.2033eng
hcfmusp.relation.referenceMaldonado JR, 2018, INT J GERIATR PSYCH, V33, P1428, DOI 10.1002/gps.4823eng
hcfmusp.relation.referenceMao L, 2020, JAMA NEUROL, V77, P683, DOI 10.1001/jamaneurol.2020.1127eng
hcfmusp.relation.referenceMarcantonio ER, 2017, NEW ENGL J MED, V377, P1456, DOI 10.1056/NEJMcp1605501eng
hcfmusp.relation.referenceMazumder H, 2020, J GERONTOL SOC WORK, V63, P257, DOI 10.1080/01634372.2020.1746723eng
hcfmusp.relation.referenceMcCusker J, 2001, J AM GERIATR SOC, V49, P1327, DOI 10.1046/j.1532-5415.2001.49260.xeng
hcfmusp.relation.referenceMcMichael TM, 2020, NEW ENGL J MED, V382, P2005, DOI 10.1056/NEJMoa2005412eng
hcfmusp.relation.referenceMunjal S, 2017, CRIT CARE CLIN, V33, P681, DOI 10.1016/j.ccc.2017.03.007eng
hcfmusp.relation.referenceO'Hanlon S, 2020, AGE AGEING, V49, P497, DOI 10.1093/ageing/afaa094eng
hcfmusp.relation.referenceSessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138eng
hcfmusp.relation.referenceTay HS, 2020, AGE AGEING, V49, P523, DOI 10.1093/ageing/afaa068eng
hcfmusp.relation.referenceToovey Stephen, 2008, Travel Med Infect Dis, V6, P114, DOI 10.1016/j.tmaid.2008.03.003eng
hcfmusp.relation.referencevan Munster BC, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-21eng
hcfmusp.relation.referenceVaratharaj A, 2020, LANCET PSYCHIAT, V7, P875, DOI 10.1016/S2215-0366(20)30287-Xeng
hcfmusp.relation.referenceWHO, 2020, CLIN MAN SEV AC RESPeng
hcfmusp.relation.referenceWitlox J, 2010, JAMA-J AM MED ASSOC, V304, P443, DOI 10.1001/jama.2010.1013eng
hcfmusp.relation.referenceWu YS, 2020, BRAIN BEHAV IMMUN, V87, P18, DOI 10.1016/j.bbi.2020.03.031eng
hcfmusp.relation.referenceZhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017eng
Appears in Collections:

Artigos e Materiais de Revistas Científicas - COVID-19

Artigos e Materiais de Revistas Científicas - FM/MCM
Departamento de Clínica Médica - FM/MCM

Artigos e Materiais de Revistas Científicas - HC/ICHC
Instituto Central - HC/ICHC

Artigos e Materiais de Revistas Científicas - LIM/66
LIM/66 - Laboratório de Investigação Médica em Envelhecimento

Files in This Item:
File Description SizeFormat 
  Restricted Access
publishedVersion (English)214.16 kBAdobe PDFView/Open Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.